Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.14
(-3.45%)
CAD 0.14
(-3.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -779.81 Thousand CAD | 20.88% |
| 2022 | -985.58 Thousand CAD | 60.72% |
| 2021 | -2.5 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -222.56 Thousand CAD | -710.16% |
| 2024 Q1 | 36.47 Thousand CAD | 145.43% |
| 2024 Q3 | -413.15 Thousand CAD | -85.63% |
| 2023 Q2 | -72.26 Thousand CAD | 74.95% |
| 2023 Q1 | -288.5 Thousand CAD | -50.69% |
| 2023 Q3 | -338.74 Thousand CAD | -368.72% |
| 2023 FY | -779.81 Thousand CAD | 20.88% |
| 2023 Q4 | -80.3 Thousand CAD | 76.29% |
| 2022 Q2 | -285.33 Thousand CAD | 5.74% |
| 2022 Q1 | -302.72 Thousand CAD | 0.0% |
| 2022 Q3 | -206.08 Thousand CAD | 27.78% |
| 2022 FY | -985.58 Thousand CAD | 60.72% |
| 2022 Q4 | -191.44 Thousand CAD | 7.1% |
| 2021 Q3 | -2.31 Million CAD | 0.0% |
| 2021 FY | -2.5 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 88.5% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 90.522% |
| BetterLife Pharma Inc. | -2.88 Million CAD | 73.008% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 89.856% |
| ChitogenX Inc. | -1.55 Million CAD | 49.819% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | 81.892% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 94.089% |
| Entheon Biomedical Corp. | -300 Thousand CAD | -159.937% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | 85.052% |
| Glow Lifetech Corp. | -1.64 Million CAD | 52.613% |
| Lexston Life Sciences Corp. | -867.71 Thousand CAD | 10.13% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | -129.459% |
| MYND Life Sciences Inc. | -1.51 Million CAD | 48.624% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | 36.312% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | 74.969% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | 38.813% |
| Telescope Innovations Corp. | -5.72 Million CAD | 86.384% |